Beyond mucosal healing: fecal calprotectin and the path toward histologic remission in ulcerative colitis.
作者信息
Park Yehyun
机构信息
Department of Internal Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.
出版信息
Intest Res. 2025 Apr;23(2):115-116. doi: 10.5217/ir.2025.00056. Epub 2025 Apr 29.
Abstract
摘要
相似文献
1
Beyond mucosal healing: fecal calprotectin and the path toward histologic remission in ulcerative colitis.超越黏膜愈合：粪便钙卫蛋白与溃疡性结肠炎组织学缓解之路
Intest Res. 2025 Apr;23(2):115-116. doi: 10.5217/ir.2025.00056. Epub 2025 Apr 29.
2
Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.溃疡性结肠炎日本患者实用粪便钙卫蛋白截断值。
World J Gastroenterol. 2018 Oct 14;24(38):4384-4392. doi: 10.3748/wjg.v24.i38.4384.
3
Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.粪便钙卫蛋白：活动性溃疡性结肠炎治疗后黏膜愈合的可靠预测指标。
Gastroenterol Res Pract. 2017;2017:2098293. doi: 10.1155/2017/2098293. Epub 2017 Oct 31.
4
Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis.基于粪便钙卫蛋白与粪便免疫化学检测评估溃疡性结肠炎黏膜愈合的比较：系统评价和荟萃分析。
Turk J Gastroenterol. 2023 Sep;34(9):892-901. doi: 10.5152/tjg.2023.22812.
5
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.粪便钙卫蛋白评估溃疡性结肠炎患者内镜和组织学缓解的价值。
Dig Dis Sci. 2018 May;63(5):1294-1301. doi: 10.1007/s10620-018-4980-0. Epub 2018 Feb 22.
6
Review article: faecal calprotectin and histologic remission in ulcerative colitis.综述文章：粪便钙卫蛋白与溃疡性结肠炎的组织学缓解。
Aliment Pharmacol Ther. 2020 Apr;51(7):689-698. doi: 10.1111/apt.15662. Epub 2020 Feb 12.
7
Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.溃疡性结肠炎临床缓解患者粪便标志物与放大内镜分层的相关性。
Digestion. 2018;97(1):82-89. doi: 10.1159/000484223. Epub 2018 Feb 1.
8
Rapid Fecal Calprotectin Testing Predicts Mucosal Healing Better than C-reactive Protein and Serum Tumor Necrosis Factor α in Patients with Ulcerative Colitis.在溃疡性结肠炎患者中，快速粪便钙卫蛋白检测比C反应蛋白和血清肿瘤坏死因子α能更好地预测黏膜愈合。
Rom J Intern Med. 2015 Jul-Sep;53(3):253-60. doi: 10.1515/rjim-2015-0033.
9
The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.粪便钙卫蛋白在预测溃疡性结肠炎深度缓解中的敏感性。
Scand J Gastroenterol. 2018 Jun-Jul;53(7):825-830. doi: 10.1080/00365521.2018.1482956. Epub 2018 Jul 3.
10
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.粪便钙卫蛋白水平与溃疡性结肠炎的内镜和组织学炎症相关，并可识别出黏膜愈合的患者。
Clin Gastroenterol Hepatol. 2015 Nov;13(11):1929-36.e1. doi: 10.1016/j.cgh.2015.05.038. Epub 2015 Jun 4.
本文引用的文献
1
Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis.粪便钙卫蛋白对溃疡性结肠炎组织学缓解的预测准确性。
Intest Res. 2025 Apr;23(2):144-156. doi: 10.5217/ir.2024.00068. Epub 2024 Nov 11.
2
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials.溃疡性结肠炎的组织学评估：临床试验中新终点的证据。
Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb;18(1-3):73-87. doi: 10.1080/17474124.2024.2326838. Epub 2024 Mar 21.
3
The evolving understanding of histology as an endpoint in ulcerative colitis.对组织学作为溃疡性结肠炎终点指标的认识不断演变。
Intest Res. 2024 Oct;22(4):389-396. doi: 10.5217/ir.2023.00120. Epub 2024 Mar 13.
4
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.美国胃肠病学会关于生物标志物在溃疡性结肠炎管理中作用的临床实践指南。
Gastroenterology. 2023 Mar;164(3):344-372. doi: 10.1053/j.gastro.2022.12.007.
5
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.在预测炎症性肠病的主要不良结局方面，肠道屏障愈合优于内镜和组织学缓解：前瞻性ERIca试验
Gastroenterology. 2023 Feb;164(2):241-255. doi: 10.1053/j.gastro.2022.10.014. Epub 2022 Oct 21.
6
Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.组织学缓解（NANCY 指数）优于内镜黏膜愈合，可预测临床和内镜缓解的溃疡性结肠炎患者的无复发生存。
J Clin Gastroenterol. 2023;57(5):494-500. doi: 10.1097/MCG.0000000000001681. Epub 2022 Feb 28.
7
Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis.粪便钙卫蛋白能否准确识别溃疡性结肠炎的组织学活动？一项荟萃分析。
Therap Adv Gastroenterol. 2021 Feb 27;14:1756284821994741. doi: 10.1177/1756284821994741. eCollection 2021.
8
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.STRIDE-II：炎症性肠病（STRIDE）国际研究组织（IOIBD）治疗靶点选择更新：确定炎症性肠病靶向治疗策略的治疗目标。
Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19.
9
Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels.比较不同组织学指标在评估 UC 活动中的应用及其在评估内镜结果和粪便钙卫蛋白水平方面的准确性。
Gut. 2019 Apr;68(4):594-603. doi: 10.1136/gutjnl-2017-315545. Epub 2018 Feb 3.
10
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.紧密控制管理对克罗恩病（CALM）的影响：一项多中心、随机、对照的 3 期临床试验。
Lancet. 2017 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31.
Zotero 插件